CBAY

Cymabay Therapeutics
CBAY

Overview Fund Activity
Delisted

CBAY was delisted on the 21st of March, 2024.

Back to rankings

113 hedge funds and large institutions have $216M invested in Cymabay Therapeutics in 2021 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 38 increasing their positions, 26 reducing their positions, and 24 closing their positions.

Holders
113
Holders Change
–
Holders Change %
0%
% of All Funds
1.75%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.09%
New
24
Increased
38
Reduced
26
Closed
24
Calls
$1.38M
Puts
$1.99M
Net Calls
-$607K
Net Calls Change
+$702K

Top Buyers

1
NCM
1
Nantahala Capital Management
Connecticut
$6.76M
2
ACM
2
Altium Capital Management
New York
$5.92M
3
DCM
3
DAFNA Capital Management
California
$6.04M
4
CC
4
Commodore Capital
New York
$18.3M
5
AAA
5
Affinity Asset Advisors
New York
$3.79M

Top Sellers

1
KPWS
1
Kestra Private Wealth Services
Texas
$0
2
ACP
2
Acuta Capital Partners
California
$0
3
Renaissance Technologies
3
Renaissance Technologies
New York
$729K
4
Two Sigma Advisers
4
Two Sigma Advisers
New York
$633K
5
OM
5
Opaleye Management
Massachusetts
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
VVM
26
Versant Venture Management
California
$1.84M – – –
Goldman Sachs
27
Goldman Sachs
New York
$1.44M +$961K +284,156 +199%
SCM
28
Stonepine Capital Management
Oregon
$1.01M +$1.01M +300,000 New
Nuveen Asset Management
29
Nuveen Asset Management
Illinois
$897K -$73.6K -23,178 -8%
FI
30
Fosun International
China
$890K – – –
Invesco
31
Invesco
Georgia
$883K +$8.85K +2,617 +1%
Bank of New York Mellon
32
Bank of New York Mellon
New York
$861K +$16.9K +5,009 +2%
AGM
33
Alpine Global Management
New York
$845K +$845K +250,000 New
D.E. Shaw & Co
34
D.E. Shaw & Co
New York
$835K -$345K -101,910 -29%
PPA
35
Parametric Portfolio Associates
Washington
$808K +$7.63K +2,258 +1%
GCP
36
GSA Capital Partners
United Kingdom
$778K -$115K -33,966 -13%
Rockefeller Capital Management
37
Rockefeller Capital Management
New York
$766K +$347K +102,850 +83%
Renaissance Technologies
38
Renaissance Technologies
New York
$729K -$1M -296,971 -58%
Massachusetts Financial Services
39
Massachusetts Financial Services
Massachusetts
$663K -$141K -41,721 -18%
Two Sigma Advisers
40
Two Sigma Advisers
New York
$633K -$665K -196,600 -51%
Charles Schwab
41
Charles Schwab
California
$609K +$20.3K +6,000 +3%
Deutsche Bank
42
Deutsche Bank
Germany
$572K +$7.48K +2,214 +1%
PM
43
Prosight Management
Texas
$564K +$564K +166,775 New
CAM
44
ClariVest Asset Management
California
$515K +$132K +39,000 +34%
CM
45
CM Management
Florida
$507K – – –
A
46
Abingworth
United Kingdom
$442K – – –
BNP Paribas Financial Markets
47
BNP Paribas Financial Markets
France
$422K +$375K +110,915 +799%
Morgan Stanley
48
Morgan Stanley
New York
$374K -$233K -69,069 -38%
AllianceBernstein
49
AllianceBernstein
Tennessee
$359K – – –
RhumbLine Advisers
50
RhumbLine Advisers
Massachusetts
$357K -$1.64K -485 -0.5%
1
2
3 4 5